Therapies with emerging evidence of efficacy: Avotermin for the improvement of scarring

Dermatology Research and Practice

Volumn 2010, Issue 1, 2010, Pages

  Bush, Jim ^a   So, Karen ^a   Mason, Tracey ^a   Occleston, Nick L ^a   O'Kane, Sharon ^a   Ferguson, Mark W J ^a  

^a Renovo   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651480429     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2010/690613     Document Type: Review

References (25)

1. Young V. L., Hutchison J., Insights into patient and clinician concerns about scarring. Plastic and Reconstructive Surgery 2009 124 1 256 265
2. Young V. L., Bush J., O'Kane S., A new approach for the prophylactic improvement of surgical scarring: avotermin (TGF β 3). Clinics in Plastic Surgery 2009 36 2 307 313 2-s2.0-62549105323 10.1016/j.cps.2008.11.008
3. Ferguson M. W. J., O'Kane S., Scar-free healing: from embryonic mechanism to adult therapeutic intervention. Philosophical Transactions of the Royal Society B 2004 359 1445 839 850 2-s2.0-2542505844 10.1098/rstb.2004.1475 (Pubitemid 38673751)
4. Meier K., Nanney L. B., Emerging new drugs for scar reduction. Expert Opinion on Emerging Drugs 2006 11 1 39 47 2-s2.0-33645114706 10.1517/14728214.11.1.39 (Pubitemid 43744798)
5. Mustoe T. A., Cooter R. D., Gold M. H., Hobbs F. D. R., Ramelet A.-A., Shakespeare P. G., Stella M., Téot L., Wood F. M., Ziegler U. E., International clinical recommendations on scar management. Plastic and Reconstructive Surgery 2002 110 2 560 571 2-s2.0-0036312318 (Pubitemid 34815962)
6. Reish R. G., Eriksson E., Scars: a review of emerging and currently available therapies. Plastic and Reconstructive Surgery 2008 122 4 1068 1078 2-s2.0-53149149431 10.1097/PRS.0b013e318185d38f
7. Reish R. G., Eriksson E., Scar treatments: preclinical and clinical studies. Journal of the American College of Surgeons 2008 206 4 719 730 2-s2.0-41149131166 10.1016/j.jamcollsurg.2007.11.022
8. Tierney E., Mahmoud B. H., Srivastava D., Ozog D., Kouba D. J., Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial. Dermatologic Surgery 2009 35 8 1172 1180 2-s2.0-68749091320 10.1111/j.1524-4725.2009.01085.x
9. Occleston N. L., O'Kane S., Goldspink N., Ferguson M. W. J., New therapeutics for the prevention and reduction of scarring. Drug Discovery Today 2008 13 21-22 973 981 2-s2.0-54049151889 10.1016/j.drudis.2008.08.009
10. Durani P., Bayat A., Levels of evidence for the treatment of keloid disease. Journal of Plastic, Reconstructive and Aesthetic Surgery 2008 61 1 4 17 2-s2.0-36649026344 10.1016/j.bjps.2007.05.007 (Pubitemid 350199116)
11. Ferguson M. W. J., Whitby D. J., Shah M., Armstrong J., Siebert J. W., Longaker M. T., Scar formation: the spectral nature of fetal and adult wound repair. Plastic and Reconstructive Surgery 1996 97 4 854 860 2-s2.0-0029970366 10.1097/00006534-199604000-00029 (Pubitemid 26089457)
12. McCallion R. L., Ferguson M. W. J., Clarke R. A. F., Fetal wound healing and the development of antiscarring therapies for adult wound healing. The Molecular and Cellular Biology of Wound Repair 1996 New York, NY, USA Plenum Press 561 600
13. O'Kane S., Ferguson M. W. J., Transforming growth factor β s and wound healing. International Journal of Biochemistry and Cell Biology 1997 29 1 63 78 2-s2.0-0031016797 10.1016/S1357-2725(96)00120-3 (Pubitemid 27096420)
14. Schrementi M. E., Ferreira A. M., Zender C., DiPietro L. A., Site-specific production of TGF- β in oral mucosal and cutaneous wounds. Wound Repair and Regeneration 2008 16 1 80 86 2-s2.0-38349089290 10.1111/j.1524-475X.2007.00320.x
15. Chen H. B., Rud J. G., Lin K., Xu L., Nuclear targeting of transforming growth factor- β -activated Smad complexes. Journal of Biological Chemistry 2005 280 22 21329 21336 2-s2.0-20444430827 10.1074/jbc.M500362200 (Pubitemid 40805695)
16. Lin R. Y., Sullivan K. M., Argenta P. A., Meuli M., Lorenz H. P., Adzick N. S., Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Annals of Surgery 1995 222 2 146 154 2-s2.0-0029135303
17. Shah M., Foreman D. M., Ferguson M. W. J., Control of scarring in adult wounds by neutralising antibody to transforming growth factor β The Lancet 1992 339 8787 213 214 2-s2.0-0026505458 10.1016/0140-6736(92)90009-R
18. Shah M., Foreman D. M., Ferguson M. W. J., Neutralisation of TGF- β 1 and TGF- β 2 or exogenous addition of TGF- β 3 to cutaneous rat wounds reduces scarring. Journal of Cell Science 1995 108 3 985 1002 2-s2.0-0028986030
19. Occleston N. L., Laverty H. G., O'Kane S., Ferguson M. W. J., Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGF β 3): from laboratory discovery to clinical pharmaceutical. Journal of Biomaterials Science 2008 19 8 1047 1063 2-s2.0-46849101477 10.1163/ 156856208784909345 (Pubitemid 351957390)
20. Durani P., Occleston N., O'Kane S., Ferguson M. W. J., Avotermin: a novel antiscarring agent. International Journal of Lower Extremity Wounds 2008 7 3 160 168 2-s2.0-49749086125 10.1177/1534734608322983
21. Laverty H., Occleston N, Jones R., Effects of transforming growth factor beta 3 in a clinically relevant model of full thickness incisional wounding in the Gottingen minipig. Wound Repair Regen. In press
22. Bond J. S., Duncan J. A. L., Sattar A., Boanas A., Mason T., O'Kane S., Ferguson M. W. J., Maturation of the human scar: an observational study. Plastic and Reconstructive Surgery 2008 121 2 487 496
23. Bond J. S., Duncan J. A. L., Mason T., Sattar A., Boanas A., O'Kane S., Ferguson M. W. J., Scar redness in humans: how long does it persist after incisional and excisional wounding? Plastic and Reconstructive Surgery 2008 121 2 487 496 2-s2.0-40749140322 10.1097/01.prs.0000299183.88334.37 (Pubitemid 351642910)
24. Duncan J. A. L., Bond J. S., Mason T., Ludlow A., Cridland P., O'Kane S., Ferguson M. W. J., Visual analogue scale scoring and ranking: a suitable and sensitive method for assessing scar quality? Plastic and Reconstructive Surgery 2006 118 4 909 918 2-s2.0-33748769530 10.1097/01.prs.0000232378.88776.b0 (Pubitemid 44412923)
25. Ferguson M. W. J., Duncan J., Bond J., Bush J., Durani P., So K., Taylor L., Chantrey J., Mason T., James G., Laverty H., Occleston N. L., Sattar A., Ludlow A., O'Kane S., Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. The Lancet 2009 373 9671 1264 1274 2-s2.0-64049103218 10.1016/S0140-6736(09) 60322-6